FAMILIAL HYPERPROINSULINEMIA ASSOCIATED WITH NIDDM - A CASE-STUDY

被引:17
作者
OOHASHI, H
OHGAWARA, H
NANJO, K
TASAKA, Y
CAO, QP
CHAN, SJ
RUBENSTEIN, AH
STEINER, DF
OMORI, Y
机构
[1] UNIV CHICAGO,HOWARD HUGHES MED INST,5841 S MARYLAND AVE,CHICAGO,IL 60637
[2] TOKYO WOMENS MED COLL,CTR DIABET,TOKYO 162,JAPAN
[3] WAKAYAMA UNIV MED SCI,DEPT MED 1,WAKAYAMA,JAPAN
[4] UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637
[5] UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637
[6] WORCESTER FDN EXPTL BIOL INC,SHREWSBURY,MA 01545
关键词
D O I
10.2337/diacare.16.10.1340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To report studies on an elderly patient with moderate NIDDM associated with marked fasting hyperinsulinemia. RESEARCH DESIGN AND METHODS - The propositus and several family members were studied by a combination of clinical, biochemical, and molecular genetic approaches to define the underlying genetic defect. RESULTS - Fasting levels of contrainsulin hormones were normal, and resistance to exogenous insulin was absent. Gel filtration and reverse-phase high-performance liquid chromatography revealed elevated amounts of a structurally abnormal proinsulin intermediate (AC proinsulin). A study of the family of the propositus showed the same abnormality in 4 of 5 members in 3 successive generations. Genetic analysis revealed a point mutation affecting residue 65 of human proinsulin (Arg-His) in one allele of the insulin gene in the propositus, a defect similar to that described previously in 3 other apparently unrelated lineages. CONCLUSIONS - This family exhibits a clear-cut relationship between increasing age and metabolic decompensation in all the hyperproinsulinemic members, suggesting that (inherited) metabolic stress and age both contribute to development of diabetes mellitus.
引用
收藏
页码:1340 / 1346
页数:7
相关论文
共 28 条
[21]  
OHMORI Y, 1976, J JPN DIABETES SOC, V19, P833
[22]   FAMILIAL HYPERPROINSULINEMIA - 2 COHORTS SECRETING INDISTINGUISHABLE TYPE-II INTERMEDIATES OF PROINSULIN CONVERSION [J].
ROBBINS, DC ;
SHOELSON, SE ;
RUBENSTEIN, AH ;
TAGER, HS .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (03) :714-719
[23]   DNA SEQUENCING WITH CHAIN-TERMINATING INHIBITORS [J].
SANGER, F ;
NICKLEN, S ;
COULSON, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (12) :5463-5467
[24]   POSTTRANSLATIONAL CLEAVAGE OF PROINSULIN IS BLOCKED BY A POINT MUTATION IN FAMILIAL HYPERPROINSULINEMIA [J].
SHIBASAKI, Y ;
KAWAKAMI, T ;
KANAZAWA, Y ;
AKANUMA, Y ;
TAKAKU, F .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (01) :378-380
[25]   3 MUTANT INSULINS IN MAN [J].
SHOELSON, S ;
HANEDA, M ;
BLIX, P ;
NANJO, A ;
SANKE, T ;
INOUYE, K ;
STEINER, D ;
RUBENSTEIN, A ;
TAGER, H .
NATURE, 1983, 302 (5908) :540-543
[26]   LESSONS LEARNED FROM MOLECULAR-BIOLOGY OF INSULIN-GENE MUTATIONS [J].
STEINER, DF ;
TAGER, HS ;
CHAN, SJ ;
NANJO, K ;
SANKE, T ;
RUBENSTEIN, AH .
DIABETES CARE, 1990, 13 (06) :600-609
[27]   STRUCTURALLY ABNORMAL INSULIN CAUSING HUMAN DIABETES [J].
TAGER, H ;
GIVEN, B ;
BALDWIN, D ;
MAKO, M ;
MARKESE, J ;
RUBENSTEIN, A ;
OLEFSKY, J ;
KOBAYASHI, M ;
KOLTERMAN, O ;
POUCHER, R .
NATURE, 1979, 281 (5727) :122-125
[28]   A NOVEL POINT MUTATION IN THE HUMAN INSULIN GENE GIVING RISE TO HYPERPROINSULINEMIA (PROINSULIN KYOTO) [J].
YANO, H ;
KITANO, N ;
MORIMOTO, M ;
POLONSKY, KS ;
IMURA, H ;
SEINO, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (06) :1902-1907